J 2003

Activation of trans geometry in bifunctional mononuclear platinum complexes by a piperidine ligand. Mechanistic studies on antitumor action

KAŠPÁRKOVÁ, Jana, Olga NOVAKOVÁ, María Victoria MARINI PALOMEQUE, Yousef NAJAJREH, Dan GIBSON et. al.

Základní údaje

Originální název

Activation of trans geometry in bifunctional mononuclear platinum complexes by a piperidine ligand. Mechanistic studies on antitumor action

Název česky

Aktivace trans geometrie bifunkcnich mononuklearnich platinovych komplexu piperidinovym ligandem.

Autoři

KAŠPÁRKOVÁ, Jana (203 Česká republika), Olga NOVAKOVÁ (203 Česká republika), María Victoria MARINI PALOMEQUE (858 Uruguay), Yousef NAJAJREH (275 Palestina), Dan GIBSON (376 Izrael), Jose-Manuel PEREZ (724 Španělsko) a Viktor BRABEC (203 Česká republika, garant)

Vydání

Journal of Biological Chemistry, Bethesda, USA, Amer. Soc. Biochem. Mol. Biol. 2003, 0021-9258

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

10610 Biophysics

Stát vydavatele

Spojené státy

Utajení

není předmětem státního či obchodního tajemství

Impakt faktor

Impact factor: 6.482

Kód RIV

RIV/00216224:14310/03:00029122

Organizační jednotka

Přírodovědecká fakulta

Klíčová slova anglicky

cisplatin; platinum complexes; DNA; antitumor
Změněno: 15. 11. 2008 17:39, Mgr. María Victoria Marini Palomeque, Ph.D.

Anotace

V originále

A paradigm for the structure-pharmacological activity relationship of bifunctional platinum antitumor drugs is that the trans isomer of antitumor cisplatin (transplatin) is clinically ineffective. To this end, however, several new complexes of the trans structure have been identified that exhibit cytotoxicity in tumor cells that is even better than that of the analogous cis isomers. We reported recently (Kasparkova, J., Marini, V., Najajreh, Y., Gibson, D., and Brabec, V. (2003) Biochemistry 42, 6321-6332) that the replacement of one ammine ligand by the heterocyclic ligand, such as piperidine, piperazine, or 4-picoline in the molecule of transplatin resulted in a radical enhancement of its cytotoxicity. We examined oligodeoxyribonucleotide duplexes bearing a site-specific cross-link of the transplatin analogue containing the piperidine ligand by biochemical methods. The results indicate that in contrast to transplatin, trans-(PtCl2(NH3)(piperidine)) forms stable 1,3-intrastrand cross-links in double-helical DNA that distort DNA and are not readily removed from DNA by nucleotide excision repair system. Hence, the intrastrand cross-links of trans-(PtCl2(NH3)(piperidine)) could persist for a sufficiently long time, potentiating its toxicity toward tumor cells. trans-(PtCl2(NH3)(piperidine)) also forms in DNA minor interstrand cross-links that are similar to those of transplatin so that these adducts appear less likely candidates for genotoxic lesion responsible for antitumor effects of trans-(PtCl2(NH3)(piperidine)). Hence, the role of structurally unique intrastrand cross-links in the anti-tumor effects of transplatin analogues in which one ammine group is replaced by a heterocyclic ligand may predominate.

Česky

cz

Návaznosti

GA305/02/1552, projekt VaV
Název: Oligonukleotidy modifikované komplexy platiny pro selektivní modulaci genové exprese; vztah k "protismyslné" strategii při vývoji nových farmak.